Adaptimmune Therapeutics : Transcript Q1 2024
Adaptimmune Q1 2024 Financial and Business Update Wednesday, May 15, 2024 - 8:00 AM ET C O R P O R A T E P A R T I C...
Stay updated with breaking news from John Lunger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adaptimmune Q1 2024 Financial and Business Update Wednesday, May 15, 2024 - 8:00 AM ET C O R P O R A T E P A R T I C...
Operator: Good morning, ladies and gentlemen, and welcome to the Adaptimmune Q1 2024 Financial and Business Update Conference Call. I would now like to turn the meeting over to Ms. Juli Miller.
ADAP earnings call for the period ending September 30, 2021.
Solving Contract Manufacturing Shortages by Going In-House May 4, 2021 In 2017, Adaptimmune opened its U.S. headquarters at the Philadelphia Navy Yard after the company outgrew its space at the University City Science Center where it had been operating since 2011. [Adaptimmune] Share Officials at Adaptimmune, which focuses on cell therapies targeting solid tumors, say the company has built in-house bioprocessing capabilities to avoid shortages in outsourcing capacity for cell and gene therapies when they started manufacturing autologous therapies four to five years ago. “The CDMO market is ...